Premium
Pelvic exenteration: a review of the Gateshead experience 1974–1992
Author(s) -
Robertson Greg,
Lopes Alberto,
Bey Gareth,
Monaghan John M.
Publication year - 1994
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1994.tb13156.x
Subject(s) - medicine , pelvic exenteration , malignancy , surgery , retrospective cohort study , general surgery , medical record
Objective To examine morbidity and survival among women treated by pelvic exenteration for gynaecological malignancy. Design Retrospective review by analysis of case records. Setting Department of Gynaecological Oncology, Queen Elizabeth Hospital, Gateshead, UK. Subjects Eighty‐three consecutive patients referred from within the UK from 1974 to 1992 for initial treatment of advanced gynaecological malignancy or management of recurrent disease following unsuccessful initial therapy. Results Overall five year actuarial survival was 41%, falling to 36 % at 10 years. Serious morbidity was low, and there were only three perioperative deaths. Conclusions For patients with limited options for treatment of advanced primary or recurrent cancer, exenteration offers a reasonable prospect of survival with good quality of life.